c-abl mediated tyrosine phosphorylation of paxillin regulates LPS-induced endothelial dysfunction and lung injury

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 308, Issue 10, 2015, Pages L1025-L1038

  Fu, Panfeng ^a   Usatyuk, Peter V ^a   Lele, Abhishek ^a   Harijith, Anantha ^a   Gregorio, Carol C ^c   Garcia, Joe G N ^c   Salgia, Ravi ^d   Natarajan, Viswanathan ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

C Abl; Cytoskeleton; Endothelial dysfunction; Lipopolysaccharide; Paxillin; Permeability; Tyrosine kinase

Indexed keywords

ABELSON KINASE; FOCAL ADHESION KINASE; LIPOPOLYSACCHARIDE; PAXILLIN; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; CADHERIN; FOCAL ADHESION KINASE 1; LEUKOCYTE ANTIGEN; PTK2 PROTEIN, HUMAN; PTK2 PROTEIN, MOUSE; PXN PROTEIN, HUMAN; PXN PROTEIN, MOUSE; TYRPHOSTIN; TYRPHOSTIN AG957; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL JUNCTION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FOCAL ADHESION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VIVO GENE TRANSFER; INFLAMMATORY CELL; LUNG INJURY; MOUSE; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ACUTE LUNG INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; CAPILLARY PERMEABILITY; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; GENE SILENCING; GENETICS; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; VASCULAR ENDOTHELIUM;

ACUTE LUNG INJURY; ANIMALS; ANTIGENS, CD; CADHERINS; CAPILLARY PERMEABILITY; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FOCAL ADHESION KINASE 1; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIPOPOLYSACCHARIDES; MALE; MICE; PAXILLIN; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-ABL; TYRPHOSTINS;

EID: 84930848017     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00306.2014     Document Type: Article

References (48)

1. Aponte M, Jiang W, Lakkis M, Li MJ, Edwards D, Albitar L, Vitonis A, Mok SC, Cramer DW, Ye B. Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/ paxillin in ovarian cancer. Cancer Res 68: 5839–5848, 2008.
2. Bannerman DD, Goldblum SE. Direct effects of endotoxin on the endothelium: barrier function and injury. Lab Invest 79: 1181–1199, 1999.
3. Birukova AA, Alekseeva E, Cokic I, Turner CE, Birukov KG. Cross talk between paxillin and Rac is critical for mediation of barrier-protective effects by oxidized phospholipids. Am J Physiol Lung Cell Mol Physiol 295: L593–L602, 2008.
4. Birukova AA, Cokic I, Moldobaeva N, Birukov KG. Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF. Am J Respir Cell Mol Biol 40: 99–107, 2009.
5. Brown MC, Cary LA, Jamieson JS, Cooper JA, Turner CE. Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusive-ness. Mol Biol Cell 16: 4316–4328, 2005.
6. Brown MC, Turner CE. Paxillin: adapting to change. Physiol Rev 84: 1315–1339, 2004.
7. Chatterjee A, Snead C, Yetik-Anacak G, Antonova G, Zeng J, Catra-vas JD. Heat shock protein 90 inhibitors attenuate LPS-induced endothe-lial hyperpermeability. Am J Physiol Lung Cell Mol Physiol 294: L755–L763, 2008.
8. Chen XL, Nam JO, Jean C, Lawson C, Walsh CT, Goka E, Lim ST, Tomar A, Tancioni I, Uryu S, Guan JL, Acevedo LM, Weis SM, Cheresh DA, Schlaepfer DD. VEGF-induced vascular permeability is mediated by FAK. Dev Cell 22: 146–157, 2012.
9. Daniel JM, Reynolds AB. Tyrosine phosphorylation and cadherin/catenin function. Bioessays 19: 883–891, 1997.
10. Daniel R, Chung SW, Eisenstein TK, Sultzer BM, Wong PM. Specific association of Type I c-Abl with Ran GTPase in lipopolysaccharide-mediated differentiation. Oncogene 20: 2618–2625, 2001.
11. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91: 1487–1500, 2001.
12. Fu P, Mohan V, Mansoor S, Tiruppathi C, Sadikot RT, Natarajan V. Role of nicotinamide adenine dinucleotide phosphate-reduced oxidase proteins in Pseudomonas aeruginosa-induced lung inflammation and permeability. Am J Respir Cell Mol Biol 48: 477–488, 2013.
13. Giannotta M, Trani M, Dejana E. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev Cell 26: 441–454, 2013.
14. Glenney JR Jr, Zokas L. Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton. J Cell Biol 108: 2401–2408, 1989.
15. Gonzalez-Lopez A, Astudillo A, Garcia-Prieto E, Fernandez-Garcia MS, Lopez-Vazquez A, Batalla-Solis E, Taboada F, Fueyo A, Al-baiceta GM. Inflammation and matrix remodeling during repair of ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 301: L500–L509, 2011.
16. Holinstat M, Knezevic N, Broman M, Samarel AM, Malik AB, Mehta D. Suppression of RhoA activity by focal adhesion kinase-induced acti vation of p190RhoGAP: role in regulation of endothelial permeability. J Biol Chem 281: 2296–2305, 2006.
17. Huang Z, Yan DP, Ge BX. JNK regulates cell migration through promotion of tyrosine phosphorylation of paxillin. Cell Signal 20: 2002–2012, 2008.
18. Iwasaki T, Nakata A, Mukai M, Shinkai K, Yano H, Sabe H, Schaefer E, Tatsuta M, Tsujimura T, Terada N, Kakishita E, Akedo H. Involvement of phosphorylation of Tyr-31 and Tyr-118 of paxillin in MM1 cancer cell migration. Int J Cancer 97: 330–335, 2002.
19. Kleveta G, Borzecka K, Zdioruk M, Czerkies M, Kuberczyk H, Sybirna N, Sobota A, Kwiatkowska K. LPS induces phosphorylation of actin-regulatory proteins leading to actin reassembly and macrophage motility. J Cell Biochem 113: 80–92, 2012.
20. Kratzer E, Tian Y, Sarich N, Wu T, Meliton A, Leff A, Birukova AA. Oxidative stress contributes to lung injury and barrier dysfunction via microtubule destabilization. Am J Respir Cell Mol Biol 47: 688–697, 2012.
21. Le Q, Daniel R, Chung SW, Kang AD, Eisenstein TK, Sultzer BM, Simpkins H, Wong PM. Involvement of C-Abl tyrosine kinase in lipopo- lysaccharide-induced macrophage activation. J Immunol 160: 3330–3336, 1998.
22. Lewis JM, Schwartz MA. Integrins regulate the association and phos-phorylation of paxillin by c-Abl. J Biol Chem 273: 14225–14230, 1998.
23. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546–1554, 2003.
24. Pasapera AM, Schneider IC, Rericha E, Schlaepfer DD, Waterman CM. Myosin II activity regulates vinculin recruitment to focal adhesions through FAK-mediated paxillin phosphorylation. J Cell Biol 188: 877–890, 2010.
25. Petit V, Boyer B, Lentz D, Turner CE, Thiery JP, Valles AM. Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells. J Cell Biol 148: 957–970, 2000.
26. Romanova LY, Hashimoto S, Chay KO, Blagosklonny MV, Sabe H, Mushinski JF. Phosphorylation of paxillin tyrosines 31 and 118 controls polarization and motility of lymphoid cells and is PMA-sensitive. J Cell Sci 117: 3759–3768, 2004.
27. Roy S, Ruest PJ, Hanks SK. FAK regulates tyrosine phosphorylation of CAS, paxillin, and PYK2 in cells expressing v-Src, but is not a critical determinant of v-Src transformation. J Cell Biochem 84: 377–388, 2002.
28. Salgia R, Li JL, Ewaniuk DS, Wang YB, Sattler M, Chen WC, Richards W, Pisick E, Shapiro GI, Rollins BJ, Chen LB, Griffin JD, Sugarbaker DJ. Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility. Oncogene 18: 67–77, 1999.
29. Scheswohl DM, Harrell JR, Rajfur Z, Gao G, Campbell SL, Schaller MD. Multiple paxillin binding sites regulate FAK function. J Mol Signal 3: 1, 2008.
30. Shephard V. Comments on “The effects of a 12-wk group exercise programme on physiological and psychological variables and function in overweight women” by Grant et al. (Public Health 2004; 118: 31–42). Public Health 118: 310, 2004.
31. Shikata Y, Birukov KG, Birukova AA, Verin A, Garcia JG. Involvement of site-specific FAK phosphorylation in sphingosine-1 phosphate-and thrombin-induced focal adhesion remodeling: role of Src and GIT. FASEB J 17: 2240–2249, 2003.
32. Shikata Y, Birukov KG, Garcia JG. S1P induces FA remodeling in human pulmonary endothelial cells: role of Rac, GIT1, FAK, and paxillin. J Appl Physiol 94: 1193–1203, 2003.
33. Shikata Y, Rios A, Kawkitinarong K, DePaola N, Garcia JG, Birukov KG. Differential effects of shear stress and cyclic stretch on focal adhesion remodeling, site-specific FAK phosphorylation, and small GT-Pases in human lung endothelial cells. Exp Cell Res 304: 40–49, 2005.
34. Singleton PA, Pendyala S, Gorshkova IA, Mambetsariev N, Moitra J, Garcia JG, Natarajan V. Dynamin 2 and c-Abl are novel regulators of hyperoxia-mediated NADPH oxidase activation and reactive oxygen species production in caveolin-enriched microdomains of the endothelium. J Biol Chem 284: 34964–34975, 2009.
35. Su G, Hodnett M, Wu N, Atakilit A, Kosinski C, Godzich M, Huang XZ, Kim JK, Frank JA, Matthay MA, Sheppard D, Pittet JF. Integrin alphavbeta5 regulates lung vascular permeability and pulmonary endothe-lial barrier function. Am J Respir Cell Mol Biol 36: 377–386, 2007.
36. Sun X, Shikata Y, Wang L, Ohmori K, Watanabe N, Wada J, Shikata K, Birukov KG, Makino H, Jacobson JR, Dudek SM, Garcia JG. Enhanced interaction between focal adhesion and adherens junction proteins: involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement. Microvasc Res 77: 304–313, 2009.
37. Teranishi S, Kimura K, Nishida T. Role of formation of an ERK-FAK-paxillin complex in migration of human corneal epithelial cells during wound closure in vitro. Invest Ophthalmol Vis Sci 50: 5646–5652, 2009.
38. Tomar A, Lim ST, Lim Y, Schlaepfer DD. A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells. J Cell Sci 122: 1852–1862, 2009.
39. Tsubouchi A, Sakakura J, Yagi R, Mazaki Y, Schaefer E, Yano H, Sabe H. Localized suppression of RhoA activity by Tyr31/118-phosphor-ylated paxillin in cell adhesion and migration. J Cell Biol 159: 673–683, 2002.
40. Turner CE. Paxillin interactions. J Cell Sci 113: 4139–4140, 2000.
41. Turner CE, Brown MC, Perrotta JA, Riedy MC, Nikolopoulos SN, McDonald AR, Bagrodia S, Thomas S, Leventhal PS. Paxillin LD4 motif binds PAK and PIX through a novel 95-kD ankyrin repeat, ARF-GAP protein: a role in cytoskeletal remodeling. J Cell Biol 145: 851–863, 1999.
42. Usatyuk PV, Burns M, Mohan V, Pendyala S, He D, Ebenezer DL, Harijith A, Fu P, Huang LS, Bear JE, Garcia JG, Natarajan V.Coronin 1B regulates S1P-induced human lung endothelial cell che-motaxis: role of PLD2, protein kinase C and Rac1 signal transduction. PLoS One 8: e63007, 2013.
43. Usatyuk PV, Natarajan V. Regulation of reactive oxygen species-induced endothelial cell-cell and cell-matrix contacts by focal adhesion kinase and adherens junction proteins. Am J Physiol Lung Cell Mol Physiol 289: L999–L1010, 2005.
44. Valles AM, Beuvin M, Boyer B. Activation of Rac1 by paxillin-Crk-DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells. J Biol Chem 279: 44490–44496, 2004.
45. Vindis C, Teli T, Cerretti DP, Turner CE, Huynh-Do U. EphB1-mediated cell migration requires the phosphorylation of paxillin at Tyr-31/Tyr-118. J Biol Chem 279: 27965–27970, 2004.
46. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334–1349, 2000.
47. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6: 154–161, 2004.
48. Yuan D, He P. Vascular remodeling alters adhesion protein and cytoskel-eton reactions to inflammatory stimuli resulting in enhanced permeability increases in rat venules. J Appl Physiol 113: 1110–1120, 2012.